News Daily News Hostility After ACS Linked to All-Cause Mortality Michael O'Riordan September 21, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Daily News Athletes Have Telltale CMR Markers of Damage Post-COVID-19, but Clinical Significance Unclear Shelley Wood September 11, 2020
News Daily News Doctors Rely on Clinic BP, Automated Tools at Patient’s Peril Michael O'Riordan September 11, 2020
News Daily News Coronary Calcium in COVID-19 Patients Linked to Worse Outcomes Yael L. Maxwell July 30, 2020
News Features Walloped by COVID-19, US Cardiology Practices Brace for Slow Recovery Todd Neale July 29, 2020
News Conference News SCCT 2020 For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change Yael L. Maxwell July 28, 2020
News Conference News SCCT 2020 ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT Yael L. Maxwell July 20, 2020
News Daily News Thrombus Burden Greater in STEMI Patients With COVID-19 Michael O'Riordan July 20, 2020
News Daily News Higher Risk of HF After ACS for Women Previously on Beta-blockers Michael O'Riordan July 16, 2020
News Daily News Too Many HF Trial Results Underreported or Never Published L.A. McKeown June 23, 2020
News Daily News Hydroxychloroquine Fails to Prevent COVID-19 in Those Exposed to the Virus: RCT Caitlin E. Cox June 05, 2020
News Daily News No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests Yael L. Maxwell May 21, 2020
News Features Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies Shelley Wood May 20, 2020
News Daily News High-Intensity Sport Post-COVID: Expert Advice From Sports Cardiologists Caitlin E. Cox May 13, 2020
News Daily News German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs L.A. McKeown May 11, 2020
News Daily News FOURIER Surveys Reassure About Cognitive Safety of Evolocumab Todd Neale May 06, 2020
News Daily News Remdesivir Study for COVID-19 Yields Positive Top-line Results Michael O'Riordan April 29, 2020